Yu Teranishi

5PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 16, 2025
Correction: Molecular insights into prognostic model for meningiomas treated with stereotactic radiosurgery: negative impacts of 1q gain on tumor control and survival.

Motoyuki Umekawa, Yuki Shinya, Yudai Hirano

|Nov 18, 2025
Sequential omics analysis reveals molecular signatures of malignant transformation in recurrent meningiomas.

Kenta Ohara, Satoru Miyawaki, Yu Teranishi

|Nov 14, 2025
Molecular insights into prognostic model for meningiomas treated with stereotactic radiosurgery: negative impacts of 1q gain on tumor control and survival.

Motoyuki Umekawa, Yuki Shinya, Yudai Hirano

|Aug 15, 2025
Merlin immunohistochemistry is a reliable surrogate marker for NF2 gene alterations in meningioma.

Mayu Kashiwagi-Hakozaki, Masako Ikemura, Satoru Miyawaki

|Oct 14, 2022
Stereotactic radiosurgery for recurrent pleomorphic adenoma of the lacrimal gland: a case report.

Motoyuki Umekawa, Keita Saito, Yuki Shinya

Pageof 1

Frequent Collaborators

5 joint publications

Masako Ikemura

5 joint publications

Nobuhito Saito

4 joint publications

Satoru Miyawaki

4 joint publications

Tetsuo Ushiku